SMS Pharmaceuticals Other Announcement

SMS Pharmaceuticals Results Update

SMS Pharmaceuticals released a press release on its Q2 and H1 FY27 results, showing strong growth. Management now expects FY27 revenue growth and EBITDA margins above earlier guidance.

SMS Pharmaceuticals Investor Presentation: Key Takeaways

Q2FY27 revenue ₹316 Cr (+30% YoY), EBITDA ₹68 Cr at 21% margin, PAT ₹40 Cr (+57%). Strategy: backward integration, high-value APIs, DMF/CEP filings, ₹280 Cr capex.

SMS Pharmaceuticals Management Change

SMS Pharmaceuticals' Company Secretary Thirumalesh Tumma resigned effective November 4, 2026. Manohar Mollama has been appointed as the new Company Secretary effective November 5, 2026.

SMS Pharmaceuticals Q2 FY27 Results: Net Profit ₹39.9 Cr, Up 57.7% YoY

SMS Pharmaceuticals Ltd reported revenue from operations of ₹316.1 Cr (+30.4% YoY) and net profit of ₹39.9 Cr (+57.7% YoY) for Q2 FY27.

Key figure

Net profit ₹39.9 Cr · +57.7% YoY

SMS Pharmaceuticals Legal & Regulatory

SMS Pharmaceuticals received an Income Tax appellate order under Section 250 dismissing its appeal for AY 2018-19. The company says there is no material impact and is reviewing next steps.

Value

₹0.40 Cr

SMS Pharmaceuticals Legal & Regulatory

SMS Pharmaceuticals disclosed that the CIT(Appeals) dismissed its appeal against a ₹7.19 Crore income tax assessment for AY 2018-19. The company is reviewing the order and expects no material impact.

Value

₹7.19 Cr

Inter State Oil Carrier Other Announcement

Inter State Oil Carrier declared related party disclosure non-applicable for half-year ended September 2026. Paid-up capital and net worth are below Regulation 15(2) limits.

Ruchira Papers Other Announcement

Ruchira Papers reconstituted its Stakeholders Relationship Committee with effect from 13 November 2026. Deepan Garg joined as a new member.

Switching Technologies Gunther Other Announcement

Switching Technologies Gunther disclosed half-year related party transactions to September 2026 under Reg 23(9). It is routine periodic disclosure, not a single new deal.

Sai Silks (Kalamandir) Other Announcement

CARE Ratings' monitoring report on Sai Silks' Rs.600 crore IPO proceeds shows no deviation from objects. It notes delays in warehouse spending, with Rs.20.27 crore unutilised.

Thermax Other Announcement

Thermax Ltd informed exchanges that its RTA, KFin Technologies, will shift its Corporate Office to a new Hyderabad address from December 1, 2026. The Registered Office is unchanged, and this is an administrative update.

Indostar Capital Finance Other Announcement

Director Hemant Kaul bought 5,001 Indostar Capital shares via market purchases from 11 to 13 November 2026. The trades total about Rs 0.10 Crore.

Value

₹0.10 Cr